FAS and chronic myelogenous leukemia, BCR-ABL1 positive: IFN-alpha increases cell death in CML patients through the Fas-mediated apoptosis pathway by increasing Fas-R expression on LSCs and increasing their exposure to cytotoxic therapy including TKIs.